Cargando…
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets
Bladder cancer is the 10th most common cancer worldwide. For muscle‐invasive bladder cancer (MIBC), treatment includes radical cystectomy, radiotherapy, and chemotherapy; however, the outcome is generally poor. For non–muscle‐invasive bladder cancer (NMIBC), tumor recurrence is common. There is an u...
Autores principales: | Burns, Julie E., Hurst, Carolyn D., Knowles, Margaret A., Phillips, Roger M., Allison, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409428/ https://www.ncbi.nlm.nih.gov/pubmed/34181805 http://dx.doi.org/10.1111/cas.15047 |
Ejemplares similares
-
Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014) -
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
por: Su, Guan-Hua, et al.
Publicado: (2023) -
Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
por: Jakobsson, Lovisa, et al.
Publicado: (2018) -
Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
por: Zechner, Dietmar, et al.
Publicado: (2016) -
Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling
por: Hurst, Carolyn D, et al.
Publicado: (2022)